AGIO Agios Pharmaceuticals, Inc.

Fundamentals / CIK 0001439222 / USD

Agios Pharmaceuticals, Inc. reported $140.8M in revenue and a net loss of $372.9M for the trailing twelve months ended September 30, 2026 (up 330.0% year over year), with a 93.8% gross margin and a -297.7% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open AGIO in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$1.63B$812.6M$0-$522.4MFY 2016 Revenue: $69.89MFY 2016 Net Income: -$198.5M2016FY 2017 Revenue: $43.01MFY 2017 Net Income: -$314.7M2017FY 2018 Revenue: $94.39MFY 2018 Net Income: -$346.0M2018FY 2019 Revenue: $117.9MFY 2019 Net Income: -$411.5M2019FY 2020 Revenue: $0FY 2020 Net Income: -$327.4M2020FY 2021 Revenue: $0FY 2021 Net Income: $1.60B2021FY 2022 Revenue: $14.24MFY 2022 Net Income: -$231.8M2022FY 2023 Revenue: $26.82MFY 2023 Net Income: -$352.1M2023FY 2024 Revenue: $36.50MFY 2024 Net Income: $673.7M2024FY 2025 Revenue: $54.03MFY 2025 Net Income: -$412.8M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $54.03M $36.50M $26.82M $14.24M $0 $0 $117.9M $94.39M $43.01M $69.89M
Cost of Revenue $6.34M $4.17M $2.88M $1.70M $0 $0 $1.32M $1.40M $0 $0
Gross Profit $47.68M $32.33M $23.94M $12.54M $0 $0 $116.6M $92.99M $43.01M $69.89M
Research & Development $339.5M $301.3M $295.5M $279.9M $257.0M $220.8M $214.3M $341.3M $292.7M $220.2M
Selling, General & Admin $180.3M $156.8M $119.9M $121.7M $121.4M $115.1M $102.0M $114.1M $71.12M $50.71M
Total Operating Expenses -- -- -- -- -- -- -- $456.9M $363.8M $270.9M
Operating Income -$472.1M -$425.7M -$391.5M -$389.0M -$378.4M -$335.9M -$316.3M -$362.5M -$320.8M -$201.0M
EBITDA -$466.9M -$420.0M -$384.9M -$380.6M -$369.6M -$326.5M -$308.2M -$355.3M -$314.4M -$195.3M
Interest Income -- -- -- $12.79M $836K $6.61M $14.86M $16.45M $6.12M $2.51M
Income Before Tax -$413.8M $718.0M -$352.1M -$231.8M -$356.5M -$329.3M -$301.4M -$346.0M -$314.7M -$198.5M
Income Tax Expense -$1.02M $44.24M $0 $0 -- -- $0 $0 $0 $0
Net Income -$412.8M $673.7M -$352.1M -$231.8M $1.60B -$327.4M -$411.5M -$346.0M -$314.7M -$198.5M
Basic EPS -$7.12 $11.86 -$6.33 -$4.23 $26.55 -$4.74 -$6.86 -$6.03 -$6.75 -$5.07
Diluted EPS -$7.12 $11.64 -$6.33 -$4.23 $26.55 -$4.74 -$6.86 -$6.03 -$6.75 -$5.07
Basic Shares Outstanding 58.0M 56.8M 55.7M 54.8M 60.4M 69.0M 60.0M 57.4M 46.6M 39.1M
Diluted Shares Outstanding 58.0M 57.9M 55.7M 54.8M 60.4M 69.0M 60.0M 57.4M 46.6M 39.1M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $55.38M $44.74M $20.75M $19.97M $12.88M $12.46M $8.73M $10.73M
Cost of Revenue $2.52M $3.00M $1.32M $1.88M $1.68M $1.70M $1.08M $1.26M
Gross Profit $52.86M $41.75M $19.43M $18.09M $11.20M $10.75M $7.64M $9.47M
Research & Development $73.49M $100.8M $81.15M $88.06M $86.80M $91.94M $72.74M $82.81M
Selling, General & Admin $56.53M $51.55M $48.30M $51.61M $41.27M $45.87M $41.53M $51.70M
Operating Income -$77.16M -$110.6M -$110.0M -$121.6M -$116.9M -$127.1M -$106.6M -$125.0M
Income Before Tax -- -- -- -- -$103.4M -- -- --
Income Tax Expense -- -- -- -- $0 -- -- --
Net Income -$65.05M -$100.7M -$99.11M -$108.0M -$103.4M -$112.0M -$89.29M -$96.52M
Basic EPS -$1.09 -$1.69 -$1.69 -- -$1.78 -$1.93 -$1.55 --
Diluted EPS -$1.09 -$1.69 -$1.69 -- -$1.78 -$1.93 -$1.55 --
Basic Shares Outstanding 59.7M 59.5M 58.8M -- 58.1M 57.9M 57.5M --
Diluted Shares Outstanding 59.7M 59.5M 58.8M -- 58.1M 57.9M 57.5M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $89.13M $76.25M $88.20M $139.3M $203.1M $127.4M $80.93M $70.50M $102.7M $160.8M
Short-Term Investments $765.3M $817.5M $688.7M $643.9M $816.9M $445.5M $483.9M $514.8M -- $380.6M
Cash & Short-Term Investments $1.20B $1.50B $806.4M $1.10B $1.29B $670.5M $717.8M $805.4M $567.8M $573.6M
Inventory $32.92M $27.62M $19.08M $8.49M $0 $14.70M $7.33M $869K $0 --
Total Current Assets $942.1M $965.6M $833.8M $832.8M $1.06B $636.7M $611.7M $613.8M $445.3M $559.9M
Property, Plant & Equipment, Net $10.78M $11.68M $15.38M $22.99M $28.92M $30.82M $31.47M $24.32M $24.43M $25.34M
Long-Term Investments $310.0M $638.3M $29.43M $313.9M $266.4M $97.61M $152.9M $220.1M -- --
Other Non-Current Assets $3.93M $4.72M $4.06M $3.96M $2.90M $0 $0 $238K $891K $1.61M
Total Non-Current Assets $355.2M $697.6M $103.3M $405.9M $373.5M $216.3M $279.0M $244.7M $169.1M $59.20M
Total Assets $1.30B $1.66B $937.1M $1.24B $1.44B $853.0M $890.7M $858.5M $614.4M $619.1M
Accounts Payable $18.36M $16.64M $9.78M $18.62M $16.70M $17.72M $21.90M $17.88M $22.77M $17.11M
Deferred Revenue (Current) -- -- -- -- $0 $0 $10.93M $32.71M $37.84M $35.91M
Total Current Liabilities $82.21M $81.16M $67.95M $62.63M $59.83M $94.39M $92.89M $93.50M $94.94M $88.43M
Deferred Revenue (Non-Current) -- -- -- -- -- $0 $50.58M $59.81M $125.8M $154.3M
Other Non-Current Liabilities $90K $880K $1.16M $3.28M $0 -- -- -- -- --
Total Non-Current Liabilities $21.91M $41.09M $58.14M $75.28M $85.94M $359.1M $157.3M $77.42M $144.0M $172.1M
Total Liabilities $104.1M $122.2M $126.1M $137.9M $145.8M $453.5M $250.2M $170.9M $238.9M $260.5M
Total Debt (incl. Leases) $40.21M $56.99M $72.00M $85.66M $97.09M $105.2M $113.7M -- -- --
Common Stock -- -- -- -- $71K $69K $68K $58K $49K $42K
Retained Earnings -$561.7M -$148.9M -$822.6M -$470.6M -$238.8M -$1.84B -$1.52B -$1.10B -$798.1M -$483.2M
Total Stockholders' Equity $1.19B $1.54B $811.0M $1.10B $1.29B $399.5M $640.5M $687.5M $375.5M $358.6M
Total Equity $1.19B $1.54B $811.0M $1.10B $1.29B $399.5M $640.5M $687.5M $375.5M $358.6M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $128.5M $99.65M $113.6M $89.13M $92.71M $80.87M $78.96M $76.25M
Short-Term Investments $501.5M $517.9M $623.4M $765.3M $860.1M $858.1M $814.4M $817.5M
Cash & Short-Term Investments $907.0M $1.00B $1.00B $1.20B $1.30B $1.30B $1.40B $1.50B
Inventory $37.84M $35.75M $35.09M $32.92M $32.03M $30.85M $29.61M $27.62M
Total Current Assets $752.1M $717.7M $834.8M $942.1M $1.03B $1.02B $968.6M $965.6M
Property, Plant & Equipment, Net $10.36M $9.95M $10.57M $10.78M $10.68M $10.58M $11.07M $11.68M
Long-Term Investments $277.0M $347.3M $308.5M $310.0M $304.3M $400.5M $531.3M $638.3M
Other Non-Current Assets $4.08M $9.68M $3.93M $3.93M $3.93M $3.94M $4.72M $4.72M
Total Non-Current Assets $311.9M $390.8M $350.1M $355.2M $352.6M $451.8M $586.9M $697.6M
Total Assets $1.06B $1.11B $1.18B $1.30B $1.39B $1.47B $1.56B $1.66B
Accounts Payable $19.93M $16.34M $13.75M $18.36M $19.55M $17.53M $13.73M $16.64M
Total Current Liabilities $77.59M $70.22M $58.84M $82.21M $74.76M $70.41M $52.37M $81.16M
Other Non-Current Liabilities $240K $240K $90K $90K $90K $101K $880K $880K
Total Non-Current Liabilities $7.12M $12.19M $17.03M $21.91M $26.62M $31.27M $36.62M $41.09M
Total Liabilities $84.70M $82.40M $75.88M $104.1M $101.4M $101.7M $88.99M $122.2M
Total Debt (incl. Leases) $26.53M $31.17M $35.74M $40.21M $44.52M $48.76M $52.94M $56.99M
Retained Earnings -$826.6M -$761.5M -$660.8M -$561.7M -$453.7M -$350.2M -$238.2M -$148.9M
Total Stockholders' Equity $979.3M $1.03B $1.11B $1.19B $1.28B $1.37B $1.47B $1.54B
Total Equity $979.3M $1.03B $1.11B $1.19B $1.28B $1.37B $1.47B $1.54B

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$412.8M $673.7M -$352.1M -$231.8M $1.60B -$327.4M -$411.5M -$346.0M -$314.7M -$198.5M
Depreciation & Amortization $5.20M $5.70M $6.60M $8.40M $8.80M $9.40M $8.09M $7.17M $6.43M $5.71M
Stock-Based Compensation $52.55M $42.85M $44.77M $49.30M $53.51M $61.60M $58.05M $73.36M $47.81M $42.09M
Change in Receivables -$6.47M -$1.30M -$604K -$2.21M $0 $0 -- -- -- --
Change in Inventory -$5.30M -$8.54M -$10.58M -$8.49M $0 $0 -$6.46M -$869K $0 $0
Change in Payables $1.75M $6.60M -$8.73M $3.44M $1.86M $3.33M $4.16M -$5.49M $5.33M $3.50M
Operating Cash Flow -$373.0M -$389.8M -$296.1M -$309.5M -$407.3M -$290.8M -$370.6M -$304.4M -$285.2M $38.56M
Capital Expenditure -$4.32M -$1.69M -$999K -$4.88M -$5.74M -$14.11M -$12.03M -$6.99M -$4.63M -$9.91M
Free Cash Flow -$377.3M -$391.5M -$297.1M -$314.4M -$413.1M -$304.9M -$382.6M -$311.4M -$289.9M $28.65M
Purchases of Investments -$641.8M -$1.54B -$417.9M -$1.03B -$1.38B -$557.0M -$488.6M -$933.3M -$688.7M --
Investing Cash Flow $377.2M $363.4M $239.6M $243.3M $1.25B $75.75M $91.44M -$273.8M -$57.91M -$119.3M
Common Stock Issued -- -- -- -- $0 $0 $277.2M $516.2M $270.2M $162.2M
Share Repurchases -- -- $0 $0 -$802.5M $0 $0 -- -- --
Financing Cash Flow $8.68M $14.44M $5.43M $2.35M -$765.8M $261.5M $289.6M $546.0M $285.1M $169.8M
Net Change in Cash $12.88M -$11.96M -$51.05M -$63.87M $75.69M $46.51M $10.43M -$32.22M -$58.03M $88.99M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$65.05M -$100.7M -$99.11M -$108.0M -$103.4M -$112.0M -$89.29M -$96.52M
Stock-Based Compensation $16.67M $15.94M $15.54M $14.12M $12.38M $14.69M $11.36M $10.90M
Change in Receivables -$5.14M -$3.98M -$5.55M -$5.55M -$43K -$1.64M $765K -$991K
Change in Inventory -$7.69M $4.93M -$2.17M -$886K -$1.19M -$1.24M -$1.99M -$1.19M
Change in Payables $2.90M $3.08M -$4.99M -$1.15M $1.81M $3.90M -$2.82M -$756K
Operating Cash Flow -$59.24M -$57.31M -$118.9M -$96.21M -$88.15M -$77.12M -$111.5M -$133.2M
Capital Expenditure -$1.18M -$1.21M -$769K -$1.12M -$1.55M -$875K -$766K -$967K
Free Cash Flow -$60.42M -$58.52M -$119.7M -$97.33M -$89.71M -$78.00M -$112.3M -$134.1M
Purchases of Investments -$87.50M -$151.6M -$148.2M -$161.1M -$175.0M -$130.8M -$174.9M -$198.3M
Investing Cash Flow $83.96M $40.21M $141.3M $90.08M $95.56M $78.97M $112.6M -$49.16M
Financing Cash Flow $4.18M $3.15M $2.08M $2.56M $4.43M $65K $1.62M $4.84M
Net Change in Cash $28.90M -$13.95M $24.47M -$3.58M $11.84M $1.91M $2.72M -$177.5M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin 88.3% 88.6% 89.3% 88.0% -- -- 98.9% 98.5% 100.0% 100.0%
Operating Margin -873.9% -1166.5% -1459.5% -2732.1% -- -- -268.2% -384.0% -745.8% -287.6%
Net Profit Margin -764.0% 1845.9% -1312.6% -1627.8% -- -- -349.0% -366.6% -731.6% -284.0%
Return on Equity (ROE) -34.6% 43.7% -43.4% -21.1% 124.2% -81.9% -64.2% -50.3% -83.8% -55.3%
Return on Assets (ROA) -31.8% 40.5% -37.6% -18.7% 111.6% -38.4% -46.2% -40.3% -51.2% -32.1%
Current Ratio 11.46x 11.90x 12.27x 13.30x 17.79x 6.74x 6.59x 6.56x 4.69x 6.33x
Quick Ratio 11.06x 11.56x 11.99x 13.16x 17.79x 6.59x 6.51x 6.55x 4.69x 6.49x
Debt to Equity 0.03x 0.04x 0.09x 0.08x 0.08x 0.26x 0.18x -- -- --
Revenue Growth (YoY) +48.0% +36.1% +88.4% -- -- -100.0% +24.9% +119.4% -38.5% +18.2%
Gross Profit Growth (YoY) +47.5% +35.0% +91.0% -- -- -100.0% +25.4% +116.2% -38.5% --
Net Income Growth (YoY) -161.3% -- -- -114.4% -- -- -- -- -- --
EPS Growth (YoY) -160.0% -- -- -115.9% -- -- -- -- -- --
Operating Cash Flow Growth (YoY) -- -- -- -- -- -- -- -- -839.7% --
Free Cash Flow Growth (YoY) -- -- -- -- -- -- -- -- -1111.8% --
5Y Revenue / Share Growth -- -67.3% -70.7% -71.8% -100.0% -100.0% +1.2% -0.8% -87.5% -75.4%
10Y Revenue / Share Growth -41.0% -66.9% -70.9% -96.5% -100.0% -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Gross Margin 93.8% 92.0% 90.0% 88.3% 87.2% 88.2% 87.5% 88.6%
Operating Margin -297.7% -466.8% -720.0% -873.9% -1061.8% -1129.1% -1188.9% -1166.5%
Net Profit Margin -264.8% -418.2% -639.8% -764.0% -895.9% 1590.4% 1798.3% 1845.9%
Return on Equity (ROE) -38.1% -40.1% -38.1% -34.6% -31.2% 47.5% 45.4% 43.7%
Return on Assets (ROA) -35.0% -37.1% -35.7% -31.8% -29.0% 44.2% 42.8% 40.5%
Current Ratio 9.69x 10.22x 14.19x 11.46x 13.82x 14.48x 18.50x 11.90x
Quick Ratio 9.21x 9.71x 13.59x 11.06x 13.39x 14.04x 17.93x 11.56x
Debt to Equity 0.03x 0.03x 0.03x 0.03x 0.03x 0.04x 0.04x 0.04x
Revenue Growth (YoY) +330.0% +259.3% +137.7% +86.1% +43.7% +44.6% +6.6% +51.1%
Gross Profit Growth (YoY) +371.9% +288.3% +154.2% +91.0% +36.9% +51.0% +1.0% +45.3%
Net Income Growth (YoY) -- -- -- -- -110.9% -- -- --
EPS Growth (YoY) -- -- -- -- -110.7% -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001439222) · from December 31, 2011 Data through September 30, 2026 · synced Nov 20, 2026, 05:24 UTC · Open in terminal